<DOC>
	<DOCNO>NCT01940666</DOCNO>
	<brief_summary>STUDY QUESTION : Which four abnormally elevate androgen group ( total testosterone [ TT ] , androstenedione [ A4 ] , free androgen index [ FAI ] , dehydroepiandrosterone-sulfate [ DHEA-S ] ) present unfavorable metabolic hormonal profile , appear insulin-resistant pose additional cardiovascular risk ? SUMMARY ANSWER : Subjects excess free androgen index tend obese face high metabolic syndrome risk , adipocytokine alteration , insulin resistance ( IR ) cardiovascular risk . The excess TT group present marginal IR risk , excess A4 group high antim√ºllerian hormone ( AMH ) , may counterbalance obesity ; group excess DHEA-S group favorable association IR .</brief_summary>
	<brief_title>Presentations Hyperandrogenic Phenotypes Taiwanese Women</brief_title>
	<detailed_description>STUDY DESIGN , SIZE , DURATION : A retrospective study 160 Taiwanese woman HA 165 woman without HA , medical record review 2009 2012 . The hyperandrogenic woman classify four group ( TT , A4 , FAI , DHEA-S ) accord independent abnormally elevated androgen measure cut-off value , group compare control . PARTICIPANTS/MATERIALS , SETTING , METHODS : This study perform Reproductive Endocrinology Clinic Wan Fang Medical Center Taipei , Taiwan . Anthropometric , metabolic , endocrine , IR component well lipid accumulation product ( LAP ) index compare group . IR assess follow marker : fast glucose insulin level , oral glucose tolerance test , glucose-to-insulin ratio homeostasis model assessment IR index ( HOMA-IR ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Hyperandrogenism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Hyperandrogenic woman classify four group : Total testosterone ( TT ) , Androstenedione ( A4 ) , Free androgen index ( FAI ) , Dehydroepiandrosterone sulphate ( DHEAS ) . According abnormally elevate androgen measure cutoff value , non hyperandrogenic woman ( androgen cutoff value ) None woman study Hypogonadotropic hypogondism , Hyperprolactinemia , Congenital adrenal hyperplasia , Premature ovarian failure , Androgensecreting tumor , Cushing 's syndrome , endocrine systemic disease may affect reproductive function , disorder uterus ( e.g . Asherman 's syndrome Mullerian genesis ) chromosomal anomaly ( e.g . Turner 's syndrome ) . In addition , exclude female Experienced menarche less three year precede study start , day 3 FSH &gt; 15 mIU/ml , well woman insufficient clinical/biochemical record , woman ovarian cyst tumor ultrasonographic examination .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Hyperandrogenism/</keyword>
	<keyword>FAI/</keyword>
	<keyword>Metabolic syndrome/</keyword>
	<keyword>Adipocytokines/</keyword>
	<keyword>Insulin resistance .</keyword>
</DOC>